Clinical Trials Logo

Cancer-related Problem/Condition clinical trials

View clinical trials related to Cancer-related Problem/Condition.

Filter by:

NCT ID: NCT05891431 Recruiting - Clinical trials for Cancer-related Problem/Condition

Engagement and Acceptability of the Untire mHealth App

Start date: December 15, 2023
Phase: N/A
Study type: Interventional

The aim of this study will be to assess the engagement and acceptability of the Untire mHealth intervention for adults with cancer related fatigue. Acceptability will be assessed after 2, 4, 6 and 12 weeks of app use. Participants (both those competed the study and those who stopped using the app) will be asked about their engagement with the app. A secondary aim of this study will be to provide preliminary efficacy outcomes of the Untire intervention in reducing fatigue and QoL in adults experiencing cancer related fatigue.

NCT ID: NCT05546736 Not yet recruiting - Quality of Life Clinical Trials

iCanWork: A Randomized Controlled Trial

iCanWork
Start date: April 1, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effectiveness of the iCanWork intervention in assisting cancer survivors (CS) to return to work (RTW) and its impact on their health-related quality of life (QoL), health service utilization, RTW readiness, time to RTW, and work capacity.

NCT ID: NCT05344625 Withdrawn - Anxiety Disorders Clinical Trials

Ketamine-Assisted PsychoTherapy ViAbility in Treating Cancer-related Emotional Distress

KAPTIVATED
Start date: October 31, 2023
Phase: Early Phase 1
Study type: Interventional

The present study will investigate if ketamine-assisted psychotherapy during palliative radiation therapy is safe, feasible, and effective at reducing psychological distress.

NCT ID: NCT05333250 Not yet recruiting - Fatigue Clinical Trials

Modafinil to Improve Fatiguability

MODIFY
Start date: April 2024
Phase: Phase 3
Study type: Interventional

Cancer-related fatigue (CRF) and cancer-related cognitive impairment (CRCI) are among the most commonly reported disabling symptoms experienced by patients with advanced cancer. However, there are currently limited evidence-based pharmacologic interventions available. The investigators will conduct a Vanguard Randomized Clinical Trial (RCT) to estimate the effect of modafinil in managing CRF and CRCI, and to test the feasibility of carrying out the study.

NCT ID: NCT05229029 Active, not recruiting - Clinical trials for Cancer-related Problem/Condition

RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy

TCM
Start date: April 2, 2020
Phase: Phase 2
Study type: Interventional

This is a multicenter, randomized, double-blind clinical trial to evaluate the efficacy and safety of Chinese herbal compound in improving fatigue symptoms and quality of life in patients with chemotherapy.

NCT ID: NCT05226078 Recruiting - Chronic Insomnia Clinical Trials

The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

Cancer-related fatigue (CRF) and insomnia are prevalent among cancer patients and have been linked to de-creases in quality of life and poorer overall survivorship. Currently, the mechanisms underlying CRF are not well understood, which has led to treatments that are only moderately effective. In addition, when compared to CBT-I in the general population, the treatment outcomes in CBT-I with cancer patients are subpar and, as such, this study will evaluate whether dose of CBT-I is effective in ameliorating CRF.

NCT ID: NCT05079334 Active, not recruiting - Clinical trials for Cancer-related Problem/Condition

Family History and Cancer Risk Study

FOREST
Start date: January 1, 2022
Phase: N/A
Study type: Interventional

Investigators from Vanderbilt University Medical Center (VUMC), Duke University, and Meharry Medical College (MMC) are collaborating on a family health history study to deploy a family health history (FHH) platform, MeTree. Recruited participants will complete surveys, the MeTree questionnaire, and MeTree will determine the participant's cancer risk based on current guidelines. The study team will offer genetic counseling to high-risk participants. Investigators will track participant outcomes and behaviors from the use of MeTree to determine the efficiency of the use of MeTree compared to completion of pedigrees in clinic.

NCT ID: NCT04950608 Active, not recruiting - Clinical trials for Cancer-related Problem/Condition

Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care

PATH
Start date: March 9, 2022
Phase: Phase 2
Study type: Interventional

The overall objective of this study is to develop and pilot test a novel regimen of psilocybin-assisted psychotherapy for demoralization in patients receiving hospice care. -The name of the study drug involved in this study is Psilocybin

NCT ID: NCT04861896 Completed - Quality of Life Clinical Trials

A Research Study for Latina Women With Breast Cancer

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the feasibility and preliminary efficacy of a psychosocial eHealth intervention designed to improve hormone therapy adherence among Hispanic/Latinx women with breast cancer. Our proposed secondary outcomes are health-related quality of life and self-efficacy in managing hormone therapy side effects. The intervention components include breast cancer knowledge, hormone/endocrine therapy knowledge, stress awareness and management, social support, and enhanced communication and intimacy skills. The intervention will be delivered via a Smartphone application over a 12-week period. All participants will receive the intervention application (described below). Aside from using the Smartphone application for the recommended 12 weeks, participation in this study includes three assessments: baseline (at the beginning of the research study), 6-week follow-up, and 12-week follow-up.

NCT ID: NCT04669301 Completed - Clinical trials for Cognitive Impairment

Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II

Start date: April 2, 2021
Phase: N/A
Study type: Interventional

Cancer-related cognitive dysfunction (CRCD) affects up to 75% of patients receiving chemotherapy and older adults are at greater risk of developing CRCD, which can negatively affect their functional independence and quality of life. Memory and Attention Adaptation Training (MAAT) is a promising treatment for CRCD that improves perceived cognition in younger cancer survivors, but needs to be adapted for older adults to address their unique needs. The proposed study will adapt MAAT for older adults using feedback from key stakeholders (older adults with cancer and their caregivers), and subsequently test the ability of MAAT to improve or maintain cognition for older adults with breast cancer receiving adjuvant chemotherapy.